Most Read Articles
Pearl Toh, 4 days ago
Every-two-month injections of the long-acting cabotegravir + rilpivirine were noninferior to once-monthly injections for virologic suppression at 48 weeks in people living with HIV*, according to the ATLAS-2M** study presented at CROI 2020 — thus providing a potential option with more convenient dosing.
Stephen Padilla, 19 Mar 2020
The assumption that children are less vulnerable to the coronavirus disease 2019 (COVID-19) compared to adults is not quite true and may even be dangerous, suggests a recent study.
22 Mar 2020
Sustained use of lopinavir-combined regimen appears to confer benefits among patients with the novel coronavirus disease (COVID-19), with improvement possibly indicated by increasing eosinophils, suggests a recent study.
24 Mar 2020
COVID-19 is a novel disease, with no existing immunity. The virus can be transmitted from person to person, quickly and exponentially. Here’s what we can do to slow down the spread, if not contain the outbreak.

High ferritin linked to gestational diabetes mellitus

18 Nov 2019

There appears to be a direct correlation between ferritin concentrations and the risk of gestational diabetes mellitus (GDM), reports a new meta-analysis.

Accessing the databases of PubMed, the Cochrane Library, Embase and Web of Science, researchers retrieved 10 observational studies corresponding to 4,690 participants. Most of the participants (n=3,650) were euglycaemic; the remaining 1,040 had GDM. Seven of the included studies scored at least 6 on the Newcastle-Ottawa Scale.

Women in the topmost category of ferritin concentrations were significantly more likely to develop GDM than their counterparts in the lowest category (summarized relative risk [SRR], 1.87, 95 percent confidence interval [CI], 1.50–2.34). Heterogeneity of evidence was null (p=0.26).

Four studies were eligible for the analysis of a dose-response relationship. Meta-analysis revealed that an increase in ferritin of 10 µg/L led to a corresponding 8-percent jump in the likelihood of developing GDM (SRR, 1.08, 95 percent CI, 1.05–1.13; p<0.01). Heterogeneity was high and of borderline significance (p=0.08).

Stratifying according to whether ferritin was measured from the plasma or serum, meta-analysis found that plasma ferritin (SRR, 2.51, 95 percent CI, 1.64–3.86) appeared to play a bigger role in GDM risk than serum ferritin (SRR, 1.63, 95 percent CI, 1.33–2.15).

The risk elevation likewise remained significant even when measurements were made during the first (SRR, 2.05, 95 percent CI, 1.39–3.02) or second (SRR, 1.79, 95 percent CI, 1.36–2.36) trimesters.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Pearl Toh, 4 days ago
Every-two-month injections of the long-acting cabotegravir + rilpivirine were noninferior to once-monthly injections for virologic suppression at 48 weeks in people living with HIV*, according to the ATLAS-2M** study presented at CROI 2020 — thus providing a potential option with more convenient dosing.
Stephen Padilla, 19 Mar 2020
The assumption that children are less vulnerable to the coronavirus disease 2019 (COVID-19) compared to adults is not quite true and may even be dangerous, suggests a recent study.
22 Mar 2020
Sustained use of lopinavir-combined regimen appears to confer benefits among patients with the novel coronavirus disease (COVID-19), with improvement possibly indicated by increasing eosinophils, suggests a recent study.
24 Mar 2020
COVID-19 is a novel disease, with no existing immunity. The virus can be transmitted from person to person, quickly and exponentially. Here’s what we can do to slow down the spread, if not contain the outbreak.